GO:0051216 cartilage development: Chondrogenesis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051216 cartilage development is the biological process by which a cartilage element progresses from formation to mature structure, producing connective tissue dominated by collagen type II and proteoglycans such as chondroitin sulfate.
• SOX9 is the master transcription factor required for chondrocyte lineage specification and cartilage formation.
• TGF-β and BMP signaling pathways are central regulators of chondrogenesis, chondrocyte proliferation, differentiation, and cartilage homeostasis.
• Primary cilia act as versatile mechanosensory and chemosensory organelles that regulate cartilage development and endochondral ossification.
• Cartilage extracellular matrix (ECM) signaling is essential for endochondral ossification, and its disruption contributes to skeletal disease.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in cartilage development and disease.
Description
Cartilage development (GO:0051216) is the biological process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage is a skeletal connective tissue dominated by an extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. This process is fundamental to endochondral ossification, joint formation, and the structural integrity of the vertebrate skeleton. Researchers study cartilage development to understand congenital skeletal disorders, osteoarthritis, and regenerative medicine strategies. The process is orchestrated by transcription factors such as SOX9, signaling pathways including TGF-β and BMP, primary cilia, and epigenetic regulators. Because cartilage is avascular and has limited intrinsic repair capacity, understanding its developmental mechanisms is critical for developing disease-modifying therapies.
cartilage development At A Glance
| GO ID | GO:0051216 |
|---|---|
| GO term | cartilage development |
| Ontology | biological_process |
| Synonym | chondrogenesis; cartilage biogenesis; cartilage biosynthesis; cartilage element development; cartilage formation; cartilage organ development |
| Major function | Progression of a cartilage element from formation to mature structure, producing connective tissue rich in collagen type II and proteoglycans such as chondroitin sulfate |
| Key regulators | SOX9, TGF-β/BMP signaling, primary cilia, ECM signaling, PTPN11, METTL3 |
| Related processes | Endochondral ossification, synovial joint development, chondrocyte differentiation and homeostasis |
| Disease relevance | Skeletal dysplasia, osteoarthritis, cartilage injury, congenital joint disorders |
What Is GO:0051216?
According to the Gene Ontology, cartilage development (GO:0051216) is the process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. Synonyms include cartilage biogenesis, cartilage biosynthesis, cartilage element development, cartilage formation, cartilage organ development, and chondrogenesis.
Why Is cartilage development Important in Cell Biology?
Cartilage development is essential for skeletal formation, joint function, and lifelong tissue homeostasis, and its dysregulation underlies a broad spectrum of human diseases including skeletal dysplasias, osteoarthritis, and impaired fracture repair. Because cartilage is avascular and has poor regenerative capacity, understanding the molecular mechanisms of chondrogenesis is critical for developing targeted therapies and tissue-engineering approaches.
• Provides the developmental blueprint for endochondral bone formation and long bone growth.
• SOX9 mutations cause campomelic dysplasia and other skeletal malformations.
• TGF-β and BMP signaling imbalances are linked to osteoarthritis and skeletal disease.
• Primary cilia dysfunction leads to chondrodysplasias and ciliopathies with skeletal features.
• ECM signaling defects impair endochondral ossification and joint integrity.
• PTPN11 dysregulation is associated with cartilage homeostasis and disease.
• METTL3-mediated m6A modification regulates cartilage development and homeostasis.
• Articular cartilage damage is a hallmark of osteoarthritis, a leading cause of disability.
• Synovial joint development depends on precise cartilage patterning.
• Cartilage development research informs regenerative medicine and CRISPR-based disease modeling.
What Happens During cartilage development?
Mesenchymal condensation and chondrogenic commitment
In simple terms: Stem-like cells cluster together and decide to become cartilage cells.
Cartilage development begins with the migration and condensation of mesenchymal progenitor cells, which then commit to the chondrogenic lineage. SOX9 is required for this commitment step and directly activates cartilage-specific extracellular matrix genes. TGF-β and BMP signaling pathways cooperate to induce and maintain the chondrogenic program during condensation.
Chondrocyte proliferation and differentiation
In simple terms: Cartilage cells multiply and mature into specialized cartilage-producing cells.
Following commitment, chondrocytes proliferate and undergo differentiation, forming the cartilage template that will later be replaced by bone in endochondral ossification. SOX9 maintains the proliferative chondrocyte pool and prevents premature hypertrophy. Primary cilia on chondrocytes sense mechanical and chemical cues that regulate proliferation and differentiation.
Extracellular matrix deposition and remodeling
In simple terms: Cartilage cells build and reshape the matrix around them.
Differentiating chondrocytes secrete a specialized extracellular matrix rich in collagen type II and proteoglycans, particularly chondroitin sulfate. ECM signaling through integrins and other receptors feeds back on chondrocyte behavior and is essential for endochondral ossification. Matrix remodeling enzymes and their inhibitors control the transition from cartilage to bone.
Endochondral ossification and joint formation
In simple terms: The cartilage template is gradually replaced by bone, and joints form at the ends of bones.
In endochondral ossification, hypertrophic chondrocytes direct vascular invasion, matrix mineralization, and replacement by bone. Synovial joint formation requires the specification of the interzone and the maintenance of articular cartilage at joint surfaces. TGF-β and BMP signaling gradients coordinate these late stages of cartilage development.
Postnatal cartilage homeostasis and epigenetic regulation
In simple terms: After birth, cartilage must be maintained, and chemical tags on RNA help control this.
Cartilage homeostasis in adults depends on the balance between anabolic and catabolic signals, and its disruption leads to osteoarthritis. METTL3-mediated m6A modification regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m6A-YTHDF2-dependent manner. PTPN11 also plays important roles in cartilage development, adult homeostasis, and disease.
Key Genes Involved in GO:0051216 cartilage development
The following genes and proteins are central to cartilage development, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX9 | Master transcription factor for chondrocyte lineage specification and cartilage matrix gene activation | Mutations cause campomelic dysplasia; key target for chondrogenesis studies |
| TGFB1 | Ligand in TGF-β signaling that promotes chondrogenesis and matrix production | Therapeutic target in osteoarthritis and cartilage repair |
| BMP2 | BMP ligand that induces chondrogenic differentiation and endochondral ossification | Used in cartilage tissue engineering and bone repair studies |
| PTPN11 | Protein tyrosine phosphatase involved in cartilage development and homeostasis | Associated with skeletal disease; model for signaling studies |
| METTL3 | m6A RNA methyltransferase regulating cartilage development via Lats1 mRNA stability | Epigenetic regulator; target for osteoarthritis research |
| COL2A1 | Major collagen type II component of cartilage extracellular matrix | Mutations cause chondrodysplasias; marker of chondrocyte differentiation |
| ACAN | Aggrecan proteoglycan core protein providing cartilage compressive resistance | Mutations cause skeletal dysplasia; marker of cartilage matrix |
| IHH | Indian hedgehog signaling regulator of chondrocyte proliferation and hypertrophy | Key regulator of endochondral ossification |
| RUNX2 | Transcription factor driving chondrocyte hypertrophy and osteoblast differentiation | Central to endochondral ossification studies |
| MMP13 | Matrix metalloproteinase degrading cartilage matrix during ossification | Marker of hypertrophic chondrocytes and osteoarthritis |
| YTHDF2 | m6A reader that destabilizes Lats1 mRNA in cartilage | Epigenetic regulator of cartilage homeostasis |
| LATS1 | Hippo pathway kinase regulated by METTL3 in cartilage | Downstream effector in cartilage development |
| GDF5 | Growth differentiation factor regulating joint formation and chondrogenesis | Associated with osteoarthritis susceptibility |
| WNT5A | Non-canonical Wnt ligand regulating chondrocyte differentiation | Modulates cartilage development and joint patterning |
| FGFR3 | Receptor tyrosine kinase that negatively regulates chondrocyte proliferation | Mutations cause achondroplasia |
| PTHLH | Parathyroid hormone-like hormone regulating chondrocyte hypertrophy | Key feedback regulator of endochondral ossification |
| IFT88 | Intraflagellar transport protein required for primary cilia formation | Cilia dysfunction impairs cartilage development |
| KIF3A | Kinesin motor protein essential for primary cilia assembly | Model for cilia-related skeletal phenotypes |
How Is cartilage development Regulated?
Cartilage development is regulated by a multilayered network of signaling pathways, transcription factors, and epigenetic modifiers. TGF-β and BMP signaling pathways control chondrogenesis, chondrocyte proliferation, differentiation, and homeostasis through SMAD-dependent and SMAD-independent mechanisms. SOX9 activity is modulated by post-translational modifications and cofactors that determine chondrocyte fate. Primary cilia transduce mechanical and chemical signals that regulate chondrocyte behavior and endochondral ossification. ECM signaling through integrins and growth factor sequestration provides feedback control of cartilage development. PTPN11 acts as a signaling modulator in cartilage development and adult homeostasis. Epigenetically, METTL3 regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m6A-YTHDF2-dependent manner.
cartilage development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SOX9 | Campomelic dysplasia and skeletal malformations | Knockout and point-mutation models in chondrogenic cells |
| COL2A1 | Chondrodysplasias and cartilage matrix defects | Knock-in of patient mutations in cell models |
| PTPN11 | Cartilage homeostasis and skeletal disease | Knockout and overexpression models |
| METTL3 | Osteoarthritis and cartilage degeneration | Knockout and point-mutation models for m6A studies |
| GDF5 | Osteoarthritis susceptibility and joint formation defects | Knock-in and overexpression models |
Skeletal dysplasias and chondrodysplasias
Mutations in genes controlling cartilage development cause a range of skeletal dysplasias. SOX9 mutations lead to campomelic dysplasia, characterized by severe skeletal malformations. Defects in collagen type II and aggrecan, the major cartilage matrix components, cause chondrodysplasias with impaired endochondral ossification. Disrupted TGF-β and BMP signaling also contributes to skeletal disease phenotypes.
Osteoarthritis and cartilage degeneration
Osteoarthritis is characterized by progressive degradation of articular cartilage, the permanent cartilage that depends on developmental programs for its maintenance. Dysregulated TGF-β and BMP signaling, ECM remodeling, and chondrocyte hypertrophy contribute to osteoarthritis pathogenesis. PTPN11 dysregulation has been linked to cartilage homeostasis and disease, making it a potential therapeutic target.
Ciliopathies with skeletal features
Primary cilia dysfunction causes ciliopathies that often include skeletal abnormalities due to impaired cartilage development. Proteins required for cilia assembly, such as IFT88 and KIF3A, are essential for normal chondrocyte signaling and endochondral ossification. These findings link ciliary biology directly to cartilage development and disease.
Epigenetic dysregulation in cartilage disease
Epigenetic modifiers such as METTL3 influence cartilage development and homeostasis through m6A-dependent regulation of Lats1 mRNA stability. Disruption of this axis may contribute to cartilage degeneration and osteoarthritis progression. Targeting epigenetic regulators is an emerging strategy for cartilage disease research.
From cartilage development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for chondrogenesis? | CRISPR knockout in chondrogenic cell lines or primary chondrocytes |
| Does a specific point mutation alter cartilage development? | CRISPR point-mutation knock-in in cell models |
| Does a disease-associated variant affect cartilage matrix production? | Knock-in of the variant with tagged readouts |
| Where and when is a cartilage gene expressed? | Tagged knock-in reporter cell lines |
| Does overexpression of a signaling factor enhance chondrogenesis? | CRISPR overexpression models |
| Which genes regulate cartilage development in a genome-wide manner? | CRISPR library screening with chondrogenic readouts |
How to Study the cartilage development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identifying pathways altered in cartilage development models |
| m6A-seq | m6A RNA modification sites | Studying METTL3-dependent regulation in cartilage |
| CRISPR knockout | Loss-of-function phenotypes | Testing requirement of candidate genes in chondrogenesis |
| CRISPR point mutation | Effect of specific variants | Modeling disease-associated mutations |
| CRISPR knock-in | Tagged or reporter gene expression | Tracking cartilage gene expression and localization |
| Histology and immunofluorescence | Tissue morphology and protein localization | Assessing cartilage matrix and chondrocyte markers |
| Western blot and co-IP | Protein levels and interactions | Dissecting signaling pathways in cartilage |
| Live imaging | Dynamic cellular behaviors | Visualizing chondrocyte differentiation and cilia |
Transcriptomic and epigenomic profiling
RNA-seq and m6A-seq can identify gene expression and epitranscriptomic changes during cartilage development, as demonstrated for METTL3-dependent regulation of Lats1 mRNA stability. These methods reveal pathways and regulators that can be validated by CRISPR models.
CRISPR-based functional genomics
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate genes in cartilage development. Library screening can systematically identify regulators of chondrogenesis and cartilage homeostasis.
Imaging and histological analysis
Histological staining, immunofluorescence, and live imaging of cartilage markers such as collagen type II and aggrecan are standard methods to assess cartilage development in vitro and in vivo. Primary cilia can be visualized to study their role in chondrocyte signaling.
Biochemical and signaling assays
Western blotting, co-immunoprecipitation, and reporter assays are used to dissect TGF-β, BMP, and PTPN11 signaling in cartilage development. These assays complement genetic models to define molecular mechanisms.
How CRISPR Can Be Used to Study GO:0051216 cartilage development
Knockout
CRISPR knockout of genes such as SOX9 or METTL3 in chondrogenic cell models can reveal their requirement for cartilage development and homeostasis. Knockout studies help distinguish essential regulators from redundant factors in chondrogenesis.
Point Mutation
CRISPR point mutation allows precise modeling of disease-associated variants in cartilage genes, such as those in PTPN11 or COL2A1. These models test whether a specific amino acid change alters chondrocyte differentiation or matrix production.
Knock-in
Knock-in of reporter tags or disease alleles enables tracking of cartilage gene expression and function in live cells. Tagged knock-in models are useful for studying protein localization and interactions during cartilage development.
Overexpression
CRISPR overexpression of signaling factors such as BMP2 or TGF-β can enhance chondrogenesis and cartilage matrix production in cell models. Overexpression models complement loss-of-function studies to define sufficiency in cartilage development.
How EDITGENE Supports cartilage development Research
Researchers studying cartilage development-related genes often need to determine whether a candidate gene is causally involved in chondrogenesis, matrix production, or disease progression. EDITGENE provides CRISPR-based cell model services that enable precise genetic perturbations to answer these questions.
Contact EDITGENE today to design your custom CRISPR model for cartilage development research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NFATC2 Knockout HEK293 Cell Line | EDJ-KQ315 | Human | 4773 | Details Get a Quote |
| WNT7A Knockout HEK293 Cell Line | EDJ-KQ355 | Human | 7476 | Details Get a Quote |
| BMP2 Knockout HEK293 Cell Line | EDJ-KQ367 | Human | 650 | Details Get a Quote |
| BMP7 Knockout HEK293 Cell Line | EDJ-KQ370 | Human | 655 | Details Get a Quote |
| GDF5 Knockout HEK293 Cell Line | EDJ-KQ380 | Human | 8200 | Details Get a Quote |
| COL2A1 Knockout HEK293 Cell Line | EDJ-KQ769 | Human | 1280 | Details Get a Quote |
| CREB3L2 Knockout HEK293 Cell Line | EDJ-KQ784 | Human | 64764 | Details Get a Quote |
| ITGB8 Knockout HEK293 Cell Line | EDJ-KQ822 | Human | 3696 | Details Get a Quote |
| EVC Knockout HEK293 Cell Line | EDJ-KQ893 | Human | 2121 | Details Get a Quote |
| SOX9 Knockout HEK293 Cell Line | EDJ-KQ928 | Human | 6662 | Details Get a Quote |
| GATA3 Knockout HEK293 Cell Line | EDJ-KQ1017 | Human | 2625 | Details Get a Quote |
| SOX6 Knockout HEK293 Cell Line | EDJ-KQ1033 | Human | 55553 | Details Get a Quote |
| GHRL Knockout HEK293 Cell Line | EDJ-KQ1782 | Human | 51738 | Details Get a Quote |
| NPR2 Knockout HEK293 Cell Line | EDJ-KQ1840 | Human | 4882 | Details Get a Quote |
| BMP3 Knockout HEK293 Cell Line | EDJ-KQ2031 | Human | 651 | Details Get a Quote |
Displaying Records 1 To 15 Of 200 Records
- 1
- 2
- ...
- 12
- 13
- Next Page »
Frequently Asked Questions About cartilage development
What is GO:0051216 cartilage development?
GO:0051216 is the biological process whose specific outcome is the progression of a cartilage element from formation to mature structure, producing connective tissue dominated by collagen type II and proteoglycans such as chondroitin sulfate.
What genes are involved in cartilage development?
Key genes include SOX9, TGFB1, BMP2, PTPN11, METTL3, COL2A1, ACAN, IHH, RUNX2, and GDF5, among others.
What is the role of SOX9 in cartilage development?
SOX9 is the master transcription factor required for chondrocyte lineage specification and activation of cartilage matrix genes.
How does TGF-β signaling regulate cartilage development?
TGF-β signaling promotes chondrogenesis, chondrocyte proliferation, and matrix production, and its dysregulation contributes to skeletal disease.
What is the role of primary cilia in cartilage development?
Primary cilia act as versatile sensory organelles that regulate chondrocyte signaling, proliferation, and endochondral ossification.
How is cartilage extracellular matrix involved in development?
The cartilage ECM, rich in collagen type II and proteoglycans, provides structural support and signals back to chondrocytes to control endochondral ossification.
What diseases are linked to defective cartilage development?
Skeletal dysplasias, chondrodysplasias, osteoarthritis, and ciliopathies with skeletal features are linked to defective cartilage development.
How can CRISPR be used to study cartilage development?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes in chondrogenesis and cartilage homeostasis.
What is the role of METTL3 in cartilage development?
METTL3 regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m6A-YTHDF2-dependent manner.
What research methods are used to study cartilage development?
Common methods include RNA-seq, m6A-seq, CRISPR screening, histology, immunofluorescence, and signaling assays.
Conclusion
Cartilage development (GO:0051216) is a tightly regulated biological process essential for skeletal formation and joint function, governed by transcription factors such as SOX9, signaling pathways including TGF-β and BMP, primary cilia, ECM signaling, and epigenetic regulators like METTL3. Dysregulation of this process underlies skeletal dysplasias, osteoarthritis, and ciliopathies, making it a critical area of biomedical research. CRISPR-based cell models and screening approaches provide powerful tools to dissect the causal roles of individual genes in cartilage development and disease.
References
- 1. Wu M et al.. 2024. The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.. Cell Res 34(2):101-123 PMID: 38267638
- 2. Lefebvre V et al.. 2019. SOX9 in cartilage development and disease.. Curr Opin Cell Biol 61:39-47 PMID: 31382142
- 3. Tao F et al.. 2020. Primary cilia: Versatile regulator in cartilage development.. Cell Prolif 53(3):e12765 PMID: 32034931
- 4. Prein C et al.. 2019. ECM signaling in cartilage development and endochondral ossification.. Curr Top Dev Biol 133:25-47 PMID: 30902255
- 5. Yang W et al.. 2025. PTPN11 in cartilage development, adult homeostasis, and diseases.. Bone Res 13(1):53 PMID: 40379623
- 6. Sheng R et al.. 2024. METTL3 regulates cartilage development and homeostasis by affecting Lats1 mRNA stability in an m(6)A-YTHDF2-dependent manner.. Cell Rep 43(8):114535 PMID: 39088322
- 7. Carballo CB et al.. 2017. Basic Science of Articular Cartilage.. Clin Sports Med 36(3):413-425 PMID: 28577703
- 8. Chijimatsu R et al.. 2019. Mechanisms of synovial joint and articular cartilage development.. Cell Mol Life Sci 76(20):3939-3952 PMID: 31201464
